C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice

References

• Diaz JA, Obi AT, Myers DD Jr., Wrobleski SK, Henke PK, Mackman N, Wakefield TW. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol. 2012;32:556–11. doi:10.1161/atvbaha.111.244608.
   PubMed Web of Science ®Google Scholar
• Albadawi H, Witting AA, Pershad Y, Wallace A, Fleck AR, Hoang P, Khademhosseini A, Oklu R. Animal models of venous thrombosis. Cardiovasc Diagn Ther. 2017;7(S3):S197–s206. doi:10.21037/cdt.2017.08.10.
   PubMedGoogle Scholar
• Jiao G, Yu G, Zhang J, Ewart HS. Chemical structures and bioactivities of sulfated polysaccharides from Marine algae. Mar Drugs. 2011;9(2):196–223. doi:10.3390/md9020196.
   PubMed Web of Science ®Google Scholar
• Necas J, Bartosikova L. Carrageenan: a review. Vet Med (Praha). 2013;58(4):187–205. doi:10.17221/6758-VETMED.
   Web of Science ®Google Scholar
• Yegappan R, Selvaprithiviraj V, Amirthalingam S, Jayakumar R. Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing. Carbohyd Polym. 2018;198:385–400. doi:10.1016/j.carbpol.2018.06.086.
   PubMed Web of Science ®Google Scholar
• Bekemeier H, Hirschelmann R, Giessler AJ. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis. Biomed Biochim Acta. 1984;43:S347–350.
   PubMedGoogle Scholar
• Bekemeier H, Hirschelmann R, Giessler AJ. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances? Agents Actions. 1985;16:446–51. doi:10.1007/bf01982887.
   PubMedGoogle Scholar
• Kindness G, Long WF, Williamson FB, Boyd J. Effects of carrageenans on the aggregation of human blood platelets. Thromb Res. 1979;15:3–15. doi:10.1016/0049-3848(79)90047-1.
   PubMed Web of Science ®Google Scholar
• Hatmi M, Randon J, Faili A, Vargaftig BB. Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway. Br J Haematol. 1993;83:270–5. doi:10.1111/j.1365-2141.1993.tb08282.x.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem. 2010;285:24494–507. doi:10.1074/jbc.M110.130575. Epub 2010/06/08.
   PubMed Web of Science ®Google Scholar
• Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem. 2012;287:22241–52. doi:10.1074/jbc.M111.329987. Epub 2012/05/05.
   PubMed Web of Science ®Google Scholar
• Inoue O, Hokamura K, Shirai T, Osada M, Tsukiji N, Hatakeyama K, Umemura K, Asada Y, Suzuki-Inoue K, Ozaki Y. Vascular smooth muscle cells stimulate platelets and facilitate thrombus formation through platelet CLEC-2: Implications in Atherothrombosis. PloS One. 2015;10:e0139357. doi:10.1371/journal.pone.0139357. Epub 20150929.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Frampton J, Watson SP. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase. Blood. 2003;102:1367–73. doi:10.1182/blood-2003-01-0029. Epub 20030501.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Shirai T, Tsukiji N, Otake S, Tamura S, Ichikawa J, Osada M, Satoh K, Ozaki Y, Suzuki-Inoue K. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis. J Thromb Haemost. 2018;16:960–72. doi:10.1111/jth.13987. Epub 20180330.
   PubMed Web of Science ®Google Scholar
• Tsukiji N, Osada M, Sasaki T, Shirai T, Satoh K, Inoue O, Umetani N, Mochizuki C, Saito T, Kojima S, et al. Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice. Blood Adv. 2018;2:2214–25. doi:10.1182/bloodadvances.2018016261.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. 2007;282:25993–6001. doi:10.1074/jbc.M702327200. Epub 2007/07/10.
   PubMed Web of Science ®Google Scholar
• Myers MJ, Deaver CM, Lewandowski AJ. Molecular mechanism of action responsible for carrageenan-induced inflammatory response. Mol Immunol. 2019;109:38–42. doi:10.1016/j.molimm.2019.02.020. Epub 20190307.
   PubMed Web of Science ®Google Scholar
• Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood. 2006;107:637–41. doi:10.1182/blood-2005-06-2202. Epub 20050922.
   PubMed Web of Science ®Google Scholar
• Galgano L, Guidetti GF, Torti M, Canobbio I. The controversial role of LPS in platelet activation in vitro. Int J Mol Sci. 2022;23: doi:10.3390/ijms231810900. Epub 20220917.
   PubMed Web of Science ®Google Scholar
• Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J Clin Invest. 2019;129:12–23. doi:10.1172/jci122955. Epub 20190102.
   PubMed Web of Science ®Google Scholar
• Tamura S, Suzuki-Inoue K, Tsukiji N, Shirai T, Sasaki T, Osada M, Satoh K, Ozaki Y. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2. Blood. 2016;127:1701–10. doi:10.1182/blood-2015-08-663708. Epub 20160121.
   PubMed Web of Science ®Google Scholar
• Bekemeier H, Giessler AJ. Thrombosis induction by different carrageenans in rats and mice. Naturwissenschaften. 1987;74:345–6. doi:10.1007/bf00367934.
   PubMedGoogle Scholar
• Bekemeier H, Hirschelmann R. Role of eicosanoids in the kappa-carrageenin rat tail thrombosis. Biomed Biochim Acta. 1988;47:S260–263.
   PubMedGoogle Scholar
• Hirschelmann R, Bekemeier H. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats. Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113:379–82.
   PubMedGoogle Scholar
• Ma N, Liu XW, Yang YJ, Li JY, Mohamed I, Liu GR, Zhang JY. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PloS One. 2015;10:e0133125. doi:10.1371/journal.pone.0133125. Epub 20150720.
   PubMed Web of Science ®Google Scholar
• Zhang B, Huang R, Yang D, Chen G, Chen Y, Han J, Zhang S, Ma L, Yang X. Combination of colchicine and ticagrelor inhibits carrageenan-induced thrombi in mice. Oxid Med Cell Longev. 2022;2022:3087198. doi:10.1155/2022/3087198. Epub 20220117.
   PubMed Web of Science ®Google Scholar
• Topalov NN, Yakimenko AO, Canault M, Artemenko EO, Zakharova NV, Abaeva AA, Loosveld M, Ataullakhanov FI, Nurden AT, Alessi MC, et al. Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). Arterioscler Thromb Vasc Biol. 2012;32:2475–83. doi:10.1161/atvbaha.112.253765. Epub 20120726.
   PubMed Web of Science ®Google Scholar
• Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood. 2017;130:2171–9. doi:10.1182/blood-2017-05-787259. Epub 20170927.
   PubMed Web of Science ®Google Scholar
• Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003;225:115–21. doi:10.1385/1-59259-374-7:115.
   PubMedGoogle Scholar
• Shang Q, Sun W, Shan X, Jiang H, Cai C, Hao J, Li G, Yu G. Carrageenan-induced colitis is associated with decreased population of anti-inflammatory bacterium, akkermansia muciniphila, in the gut microbiota of C57BL/6J mice. Toxicol Lett. 2017;279:87–95. doi:10.1016/j.toxlet.2017.07.904. Epub 20170801.
   PubMed Web of Science ®Google Scholar
• Mi Y, Chin YX, Cao WX, Chang YG, Lim PE, Xue CH, Tang QJ. Native κ-carrageenan induced-colitis is related to host intestinal microecology. Int J Biol Macromol. 2020;147:284–94. doi:10.1016/j.ijbiomac.2020.01.072. Epub 20200108.
   PubMed Web of Science ®Google Scholar
• Lopes AH, Silva RL, Fonseca MD, Gomes FI, Maganin AG, Ribeiro LS, Marques LMM, Cunha FQ, Alves-Filho JC, Zamboni DS, et al. Molecular basis of carrageenan-induced cytokines production in macrophages. Cell Commun Signal. 2020;18:141. doi:10.1186/s12964-020-00621-x. Epub 20200907.
   PubMed Web of Science ®Google Scholar
• Arslan R, Bor Z, Bektas N, Meriçli AH, Ozturk Y. Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model. Thromb Res. 2011;127:210–3. doi:10.1016/j.thromres.2010.11.028. Epub 20101222.
   PubMed Web of Science ®Google Scholar
• Barth CR, Funchal GA, Luft C, de Oliveira JR, Porto BN, Donadio MV. Carrageenan-induced inflammation promotes ROS generation and neutrophil extracellular trap formation in a mouse model of peritonitis. Eur J Immunol. 2016;46:964–70. doi:10.1002/eji.201545520. Epub 20160208.
   PubMed Web of Science ®Google Scholar
• Manne BK, Getz TM, Hughes CE, Alshehri O, Dangelmaier C, Naik UP, Watson SP, Kunapuli SP. Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2). J Biol Chem. 2013;288:7717–26. doi:10.1074/jbc.M112.424473. Epub 20130122.
   PubMed Web of Science ®Google Scholar
• Alshehri OM, Montague S, Watson S, Carter P, Sarker N, Manne BK, Miller JL, Herr AB, Pollitt AY, O’Callaghan CA, et al. Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands. Biochem J. 2015;468:459–73. doi:10.1042/bj20150192. Epub 20150407.
   PubMed Web of Science ®Google Scholar
• Kardeby C, Fälker K, Haining EJ, Criel M, Lindkvist M, Barroso R, Påhlsson P, Ljungberg LU, Tengdelius M, Rainger GE, et al. Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα. Blood Adv. 2019;3:275–87. doi:10.1182/bloodadvances.2018024950.
   PubMed Web of Science ®Google Scholar
• Dul M, Paluch KJ, Kelly H, Healy AM, Sasse A, Tajber L. Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-investigation of critical parameters governing their formation and characteristics. Carbohydr Polym. 2015;123:339–49. doi:10.1016/j.carbpol.2015.01.066. Epub 20150207.
   PubMed Web of Science ®Google Scholar
• Martin EM, Zuidscherwoude M, Morán LA, Di Y, García A, Watson SP. The structure of CLEC-2: mechanisms of dimerization and higher-order clustering. Platelets. 2021;32:733–43. doi:10.1080/09537104.2021.1906407. Epub 20210405.
   PubMed Web of Science ®Google Scholar
• Brown GD, Willment JA, Whitehead L. C-type lectins in immunity and homeostasis. Nat Rev Immunol. 2018;18:374–89. doi:10.1038/s41577-018-0004-8.
   PubMed Web of Science ®Google Scholar
• Evaluations of the Joint FAO/WHO expert committee on food additives (JECFA). https://apps.who.int/food-additives-contaminants-jecfa-database/Home/Chemical/377.
   Google Scholar